Portland scientists at Oregon Health & Science University say they have figured out why pancreatic tumors so often brush off immunotherapy, and how to flip that script so the same tumors start inviting an immune attack instead. In lab studies, the team found that stimulating an immune receptor called CD40 can reprogram the regulatory T cells that usually help tumors hide, turning those cells into ones that pump out inflammatory, tumor‑fighting signals. The findings, detailed in a new paper out this week, point to combination strategies that could finally make immunotherapy useful against pancreatic cancer.
According to Oregon Health & Science University, the group showed that pancreatic tumors actively reshape their immune microenvironment by hijacking regulatory T cells, and that activating CD40 in laboratory models can reverse that program. “Pancreatic cancer is incredibly resistant to most therapies,” said senior author Katelyn Byrne, Ph.D., in a statement. The university added that truly effective treatments may have to pull off a one‑two punch, simultaneously switching on the immune system and disabling the tumor’s built‑in ability to shut it back down.
How Researchers Rewired Suppressive Cells
In work reported in the journal Immunity, the team used spatiotemporal imaging and lineage tracing in mouse models of pancreatic ductal adenocarcinoma to track what happens when they hit tumors with an agonistic anti‑CD40 antibody. The treatment reduced the number of FoxP3+ regulatory T cells inside the tumors and generated an “ExTreg” population that lost FoxP3 expression while gaining the transcription factor T‑bet and the inflammatory cytokine interferon‑gamma. These ExTreg cells clustered near CXCL9‑expressing dendritic cells and showed the strongest antigen‑driven activation of any T cells in the tumors, suggesting that the reprogrammed cells could help drive tumor rejection. The experiments combined imaging, genetic tracing and functional assays to chart how pancreatic tumors rewire immune cells in their local environment.
What This Could Mean for Treatment…